vs
BALCHEM CORP(BCPC)与Solstice Advanced Materials Inc.(SOLS)财务数据对比。点击上方公司名可切换其他公司
Solstice Advanced Materials Inc.的季度营收约是BALCHEM CORP的3.7倍($969.0M vs $263.6M)。BALCHEM CORP净利率更高(14.9% vs -3.6%,领先18.5%)。BALCHEM CORP同比增速更快(9.8% vs 6.8%)
Balchem Corp是一家全球特种化学品与营养原料供应商,核心业务覆盖人类营养、动物保健、制药、工业应用四大领域,为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
Solstice Advanced Materials Inc.是一家特种先进材料供应商,专注于研发、生产及销售高性能功能材料,产品覆盖可再生能源、消费电子、工业制造、先进汽车等领域,其材料解决方案可帮助全球客户提升产品耐用性与能源利用效率。
BCPC vs SOLS — 直观对比
营收规模更大
SOLS
是对方的3.7倍
$263.6M
营收增速更快
BCPC
高出3.0%
6.8%
净利率更高
BCPC
高出18.5%
-3.6%
损益表 — Q4 2025 vs Q3 2025
| 指标 | ||
|---|---|---|
| 营收 | $263.6M | $969.0M |
| 净利润 | $39.2M | $-35.0M |
| 毛利率 | 35.6% | 32.0% |
| 营业利润率 | 19.8% | 17.9% |
| 净利率 | 14.9% | -3.6% |
| 营收同比 | 9.8% | 6.8% |
| 净利润同比 | 16.8% | -123.0% |
| 每股收益(稀释后) | $1.21 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BCPC
SOLS
| Q4 25 | $263.6M | — | ||
| Q3 25 | $267.6M | $969.0M | ||
| Q2 25 | $255.5M | — | ||
| Q1 25 | $250.5M | — | ||
| Q4 24 | $240.0M | — | ||
| Q3 24 | $239.9M | $907.0M | ||
| Q2 24 | $234.1M | — | ||
| Q1 24 | $239.7M | — |
净利润
BCPC
SOLS
| Q4 25 | $39.2M | — | ||
| Q3 25 | $40.3M | $-35.0M | ||
| Q2 25 | $38.3M | — | ||
| Q1 25 | $37.1M | — | ||
| Q4 24 | $33.6M | — | ||
| Q3 24 | $33.8M | $152.0M | ||
| Q2 24 | $32.1M | — | ||
| Q1 24 | $29.0M | — |
毛利率
BCPC
SOLS
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | 32.0% | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | 36.6% | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
营业利润率
BCPC
SOLS
| Q4 25 | 19.8% | — | ||
| Q3 25 | 20.4% | 17.9% | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | 20.4% | — | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.0% | 21.7% | ||
| Q2 24 | 19.6% | — | ||
| Q1 24 | 17.4% | — |
净利率
BCPC
SOLS
| Q4 25 | 14.9% | — | ||
| Q3 25 | 15.1% | -3.6% | ||
| Q2 25 | 15.0% | — | ||
| Q1 25 | 14.8% | — | ||
| Q4 24 | 14.0% | — | ||
| Q3 24 | 14.1% | 16.8% | ||
| Q2 24 | 13.7% | — | ||
| Q1 24 | 12.1% | — |
每股收益(稀释后)
BCPC
SOLS
| Q4 25 | $1.21 | — | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $1.17 | — | ||
| Q1 25 | $1.13 | — | ||
| Q4 24 | $1.03 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.98 | — | ||
| Q1 24 | $0.89 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $417.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $3.2B |
| 总资产 | $1.7B | $5.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
BCPC
SOLS
| Q4 25 | $74.6M | — | ||
| Q3 25 | $65.1M | $417.0M | ||
| Q2 25 | $65.4M | — | ||
| Q1 25 | $49.9M | — | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $63.7M | — | ||
| Q1 24 | $60.3M | — |
股东权益
BCPC
SOLS
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $3.2B | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.2B | $3.2B | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
总资产
BCPC
SOLS
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | $5.2B | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $67.3M | $289.0M |
| 自由现金流经营现金流 - 资本支出 | — | $41.0M |
| 自由现金流率自由现金流/营收 | — | 4.2% |
| 资本支出强度资本支出/营收 | — | 25.6% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
BCPC
SOLS
| Q4 25 | $67.3M | — | ||
| Q3 25 | $65.6M | $289.0M | ||
| Q2 25 | $47.3M | — | ||
| Q1 25 | $36.5M | — | ||
| Q4 24 | $52.3M | — | ||
| Q3 24 | $51.3M | — | ||
| Q2 24 | $45.0M | — | ||
| Q1 24 | $33.4M | — |
自由现金流
BCPC
SOLS
| Q4 25 | — | — | ||
| Q3 25 | — | $41.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
BCPC
SOLS
| Q4 25 | — | — | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
BCPC
SOLS
| Q4 25 | — | — | ||
| Q3 25 | — | 25.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率
BCPC
SOLS
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
SOLS
| Refrigerants | $400.0M | 41% |
| Research And Performance Chemicals | $126.0M | 13% |
| Electronic Materials | $103.0M | 11% |
| Other | $89.0M | 9% |
| Services | $64.0M | 7% |
| Alternative Energy Services | $63.0M | 7% |
| Safety And Defense Solutions | $53.0M | 5% |
| Healthcare Packaging | $49.0M | 5% |
| Affiliated Entity | $22.0M | 2% |